Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epilepsy in Youth”

Showing 15 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT03108729
What this trial is testing

A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug

Who this might be right for
Epilepsy
Sumitomo Pharma America, Inc.
Large-scale testing (Phase 3)Ended earlyNCT00698581
What this trial is testing

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 88
Testing effectiveness (Phase 2)Study completedNCT02170064
What this trial is testing

Pharmacokinetics, Efficacy and Tolerability of BIA 2-093

Who this might be right for
Epilepsy
Bial - Portela C S.A. 35
Testing effectiveness (Phase 2)Study completedNCT01161524
What this trial is testing

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Who this might be right for
Epilepsy
Eisai Inc. 133
Testing effectiveness (Phase 2)Study completedNCT02925663
What this trial is testing

Web-based Intervention to Improve Executive Functioning in Teens With Epilepsy (Epilepsy Journey)

Who this might be right for
Epilepsy
Children's Hospital Medical Center, Cincinnati 32
Large-scale testing (Phase 3)Study completedNCT00368251
What this trial is testing

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults

Who this might be right for
Unverricht-Lundborg Disease
UCB Pharma 56
Testing effectiveness (Phase 2)Study completedNCT00422422
What this trial is testing

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Who this might be right for
Epilepsy
UCB Pharma 100
Not applicableLooking for participantsNCT06608966
What this trial is testing

Epilepsy Journey-An Executive Functioning Intervention for Teens With Epilepsy

Who this might be right for
Epilepsy in ChildrenExecutive Dysfunction
Children's Hospital Medical Center, Cincinnati 310
Not applicableStudy completedNCT01550874
What this trial is testing

STEP: Enhanced Physical Activity in Children and Youth With Epilepsy

Who this might be right for
Epilepsy
McMaster University 122
Not applicableStudy completedNCT00550940
What this trial is testing

Emotion/Behavior Problems, Neuropsychological Functioning, and Parental Adjustment in Children With Epilepsy

Who this might be right for
Epilepsy
National Taiwan University Hospital 65
Not applicableWithdrawnNCT03368469
What this trial is testing

Transcranial Direct Current Stimulation (tDCS) in Children and Adolescents With Epilepsy and Depression

Who this might be right for
Depressive DisorderGeneralized Epilepsy
Mayo Clinic
Not applicableNot Yet RecruitingNCT05660239
What this trial is testing

Impact of a Community Based Engagement Program Focused on Adolescents With Epilepsy

Who this might be right for
Epilepsy
Makerere University 70
Not applicableStudy completedNCT05066360
What this trial is testing

Serum Antimullerian Hormone Levels Among Epileptic Patients

Who this might be right for
EpilepsyReproductive Issues
Near East University, Turkey 60
Large-scale testing (Phase 3)Study completedNCT04938427
What this trial is testing

Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome

Who this might be right for
Lennox Gastaut Syndrome (LGS)
Takeda 270
Large-scale testing (Phase 3)Study completedNCT00210483
What this trial is testing

3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents

Who this might be right for
Migraine
Janssen-Ortho LLC 866

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation